Physician profile
Catherine Smith
NPI 1760281729
$328.83
in general payments reported to CMS, 2019-2025
10 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $66.89 | 2025 | Nexplanon |
| Avation Medical, INC. | $48.77 | 2025 | Vivally System |
| Sumitomo Pharma America, INC. | $48.37 | 2025 | Myfembree |
| Astellas Pharma US INC | $43.09 | 2025 | Veozah |
| Dexcom, INC. | $29.12 | 2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $24.91 | 2025 | Truclear |
| Novo Nordisk INC | $18.55 | 2025 | Wegovy |
| Exeltis, USA INC. | $18.19 | 2025 | Slynd |
| Biogen, INC. | $16.72 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $14.22 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.